These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 35356990

  • 1. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort.
    Van Muijen ME, Thomas SE, Groenewoud HMM, Otero ME, Ossenkoppele PM, Njoo MD, Dodemont SRP, Kop EN, Berends MAM, Koetsier MIA, Mommers JM, Körver JEM, Tupker RA, De Bruin-Weller MS, Weppner-Parren LJMT, Peters B, Kleinpenning MM, Kuijpers ALA, Arnold WP, Van Lümig PPM, Van den Reek JMPA, De Jong EMGJ.
    Acta Derm Venereol; 2022 May 16; 102():adv00712. PubMed ID: 35356990
    [Abstract] [Full Text] [Related]

  • 2. Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis.
    Yiu ZZN, Becher G, Kirby B, Laws P, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM, BADBIR Study Group.
    JAMA Dermatol; 2022 Oct 01; 158(10):1131-1141. PubMed ID: 35791876
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany.
    Augustin M, McBride D, Gilloteau I, O'Neill C, Neidhardt K, Graham CN.
    J Eur Acad Dermatol Venereol; 2018 Dec 01; 32(12):2191-2199. PubMed ID: 29729105
    [Abstract] [Full Text] [Related]

  • 8. Effects of TNF inhibitors and an IL12/23 inhibitor on changes in body weight and adipokine levels in psoriasis patients: a 48-week comparative study.
    Onsun N, Akaslan TÇ, Sallahoglu K, Gülcan AS, Bulut H, Yabacı A.
    J Dermatolog Treat; 2022 May 01; 33(3):1727-1732. PubMed ID: 33704001
    [Abstract] [Full Text] [Related]

  • 9. Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
    Tada Y, Watanabe R, Noma H, Kanai Y, Nomura T, Kaneko K.
    J Dermatol Sci; 2020 Jul 01; 99(1):53-61. PubMed ID: 32600737
    [Abstract] [Full Text] [Related]

  • 10. Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study.
    Schwarz CW, Loft N, Rasmussen MK, Nissen CV, Dam TN, Ajgeiy KK, Egeberg A, Skov L.
    Acta Derm Venereol; 2021 Oct 26; 101(10):adv00579. PubMed ID: 34642768
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis.
    Xue W, Saharia P, Gray E, Khoudigian-Sinani S, Gaudet V, Barbeau M, Papp K.
    J Cutan Med Surg; 2020 Oct 26; 24(6):561-572. PubMed ID: 32588642
    [Abstract] [Full Text] [Related]

  • 12. PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis.
    Carrera CG, Dapavo P, Malagoli P, Naldi L, Arancio L, Gaiani F, Egan CG, Di Mercurio M, Cattaneo A.
    J Dermatolog Treat; 2018 Aug 26; 29(5):481-486. PubMed ID: 29058948
    [Abstract] [Full Text] [Related]

  • 13. Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).
    Strober BE, Bissonnette R, Fiorentino D, Kimball AB, Naldi L, Shear NH, Goyal K, Fakharzadeh S, Calabro S, Langholff W, You Y, Galindo C, Lee S, Lebwohl MG.
    J Am Acad Dermatol; 2016 May 26; 74(5):851-61.e4. PubMed ID: 26853180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Ramaekers BLT, Wolff RF, Pouwels X, Oosterhoff M, Van Giessen A, Worthy G, Noake C, Armstrong N, Kleijnen J, Joore MA.
    Pharmacoeconomics; 2018 Aug 26; 36(8):917-927. PubMed ID: 29480455
    [Abstract] [Full Text] [Related]

  • 16. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C, Marshman G, Grillo M, Stanford T.
    Australas J Dermatol; 2016 May 26; 57(2):137-40. PubMed ID: 25754697
    [Abstract] [Full Text] [Related]

  • 17. Biologics for Psoriasis.
    Wride AM, Chen GF, Spaulding SL, Tkachenko E, Cohen JM.
    Dermatol Clin; 2024 Jul 26; 42(3):339-355. PubMed ID: 38796266
    [Abstract] [Full Text] [Related]

  • 18. Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan.
    Chen YC, Huang YT, Yang CC, Lai EC, Liu CH, Hsu CK, Wong TW, Chao SC, Sheu HM, Lee CN.
    PLoS One; 2020 Jul 26; 15(12):e0244620. PubMed ID: 33373425
    [Abstract] [Full Text] [Related]

  • 19. Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort.
    Zweegers J, Roosenboom B, van de Kerkhof PC, van den Reek JM, Otero ME, Atalay S, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Bijen M, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM.
    Br J Dermatol; 2017 Mar 26; 176(3):786-793. PubMed ID: 27454758
    [Abstract] [Full Text] [Related]

  • 20. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study.
    Talamonti M, Galluzzo M, Bernardini N, Caldarola G, Persechino S, Cantoresi F, Egan CG, Potenza C, Peris K, Bianchi L.
    J Eur Acad Dermatol Venereol; 2018 Oct 26; 32(10):1737-1744. PubMed ID: 29776016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.